Sanara MedTech Inc. SMTI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $27.8M+0.9% | $27.55M+4.6% | $26.33M+1.9% | $25.83M+10.2% | $23.43M-10.9% | ||
| $1.92M+2.6% | $1.87M0.0% | $1.87M-3.3% | $1.94M+5.6% | $1.83M-18.4% | ||
| $25.87M+0.8% | $25.67M+5.0% | $24.46M+2.4% | $23.89M+10.6% | $21.6M-10.2% | ||
| 93.1%-0.1pp | 93.2%+0.3pp | 92.9%+0.4pp | 92.5%+0.3pp | 92.2%+0.7pp | ||
| $759.59K-62.7% | $2.04M+97.7% | $1.03M-18.1% | $1.26M+32.3% | $950.36K+7.6% | ||
| $21.88M+9.0% | $20.08M+1.0% | $19.88M-7.8% | $21.55M+12.7% | $19.13M-5.4% | ||
| $23.23M-5.7% | $24.62M+14.4% | $21.52M-10.1% | $23.92M+15.2% | $20.77M-4.7% | ||
| $2.65M+152% | $1.05M-64.3% | $2.94M+9,483% | -$31.35K-104% | $825.53K-63.5% | ||
| 9.5%+5.7pp | 3.8%-7.4pp | 11.2%+11.3pp | -0.1%-3.6pp | 3.5%-5.1pp | ||
| $1.8M-1.8% | $1.83M+0.8% | $1.82M+1.5% | $1.79M+36.0% | $1.32M+2.2% | ||
| -$2.25M-4.2% | -$2.16M-2.4% | -$2.11M-6.0% | -$1.99M-37.4% | -$1.45M-9.1% | ||
| $458.96K+129% | -$1.61M+94.7% | -$30.41M-1,410% | -$2.01M+42.9% | -$3.53M-129% | ||
| 1.7%+7.5pp | -5.8%+110pp | -115.5%-108pp | -7.8%+7.3pp | -15.1%-9.2pp | ||
| $0.05+116% | -$0.32+90.6% | -$3.40-1,378% | -$0.23+43.9% | -$0.41-128% | ||
| $3.23M+88.1% | $1.72M-56.8% | $3.98M+268% | $1.08M-44.5% | $1.95M-49.6% | ||
| 11.6%+5.4pp | 6.2%-8.9pp | 15.1%+10.9pp | 4.2%-4.1pp | 8.3%-6.4pp | ||
| $2.65M+152% | $1.05M-64.3% | $2.94M+9,483% | -$31.35K-104% | $825.53K-63.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Sanara MedTech Inc.'s revenue?
- Sanara MedTech Inc. (SMTI) generated $107.5M in revenue over the trailing twelve months, up 17.4% year over year.
- Is Sanara MedTech Inc. profitable?
- Sanara MedTech Inc. is not currently profitable: it reported a net loss of $33.6M over the trailing twelve months, a -31.2% net margin.
- What are Sanara MedTech Inc.'s profit margins?
- Gross margin is 92.9% and operating margin is 6.1%, with a -31.2% net margin.
- What is Sanara MedTech Inc.'s earnings per share?
- Sanara MedTech Inc.'s diluted EPS over the trailing twelve months is $-3.90.
- Where does Sanara MedTech Inc.'s income statement data come from?
- Every line is extracted from Sanara MedTech Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
